Larazotide
Also known as: AT-1001 · Larazotide acetate
A tight-junction regulator and zonulin antagonist developed for celiac disease, physically sealing the 'leaky gut' at its mechanical root cause.
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
~4–6 hours
0.5 mg three times daily
Oral
Mechanism of Action
Blocks zonulin-mediated opening of intestinal tight junctions, preventing gluten-induced paracellular permeability increase.
Key Research Areas
Frequently Asked Questions
What is Larazotide?▾
How does Larazotide work?▾
What is the recommended dosage for Larazotide?▾
What is the half-life of Larazotide?▾
Is Larazotide FDA approved?▾
Ready to get started with Larazotide?
Order from our COA-verified partner — free US shipping, pharmaceutical-grade quality.
Research Disclaimer
The information provided about Larazotide is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.